- Home
- DOW vs ZBH Comparison
DOW vs ZBH Comparison
Compare DOW & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOW
- ZBH
- Stock Information
- Founded
- DOW 1897
- ZBH 1927
- Country
- DOW United States
- ZBH United States
- Employees
- DOW N/A
- ZBH N/A
- Industry
- DOW Major Chemicals
- ZBH Industrial Specialties
- Sector
- DOW Industrials
- ZBH Health Care
- Exchange
- DOW Nasdaq
- ZBH Nasdaq
- Market Cap
- DOW 16.3B
- ZBH 19.9B
- IPO Year
- DOW N/A
- ZBH N/A
- Fundamental
- Price
- DOW $22.16
- ZBH $88.57
- Analyst Decision
- DOW Hold
- ZBH Buy
- Analyst Count
- DOW 15
- ZBH 19
- Target Price
- DOW $27.13
- ZBH $109.00
- AVG Volume (30 Days)
- DOW 13.4M
- ZBH 2.1M
- Earning Date
- DOW 10-23-2025
- ZBH 11-05-2025
- Dividend Yield
- DOW 6.28%
- ZBH 1.08%
- EPS Growth
- DOW N/A
- ZBH N/A
- EPS
- DOW N/A
- ZBH 4.03
- Revenue
- DOW $40,913,000,000.00
- ZBH $8,010,900,000.00
- Revenue This Year
- DOW N/A
- ZBH $8.20
- Revenue Next Year
- DOW $2.54
- ZBH $5.92
- P/E Ratio
- DOW N/A
- ZBH $21.94
- Revenue Growth
- DOW N/A
- ZBH 5.47
- 52 Week Low
- DOW $20.40
- ZBH $85.33
- 52 Week High
- DOW $48.92
- ZBH $114.72
- Technical
- Relative Strength Index (RSI)
- DOW 42.56
- ZBH 31.42
- Support Level
- DOW $22.56
- ZBH $85.33
- Resistance Level
- DOW $23.22
- ZBH $103.69
- Average True Range (ATR)
- DOW 0.72
- ZBH 2.85
- MACD
- DOW -0.15
- ZBH -1.53
- Stochastic Oscillator
- DOW 14.16
- ZBH 15.03
About DOW Dow Inc.
Dow Chemical is a diversified global chemicals producer, formed in 2019 as a result of the DowDuPont merger and subsequent separations. The firm is a leading producer of several chemicals, including polyethylene, ethylene oxide, and silicone rubber. Its products have numerous applications in both consumer and industrial end markets.
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.